Heidi L Moline

Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus–Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season — New Vaccine Surveillance Network, October 2023–February 2024

R. Link-Gelles, F. Dawood, R. Selvarangan, 2024, MMWR. Morbidity and mortality weekly report.

Respiratory Syncytial Virus-Associated Hospitalizations Among Children <5 Years Old: 2016 to 2020.

A. Curns, R. Selvarangan, J. Boom, 2024, Pediatrics.

Accuracy of Influenza ICD-10 Diagnosis Codes in Identifying Influenza Illness in Children

R. Selvarangan, J. Boom, M. Staat, 2024, JAMA network open.